Stock listing
PEPG Stock Price, News, Filings & Events — Pepgen Inc.
Selected listing: PEPG · BOATS · USD · US
This page tracks Pepgen Inc.'s PEPG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PEPG:BOATS. PEPG:BOATS is the stock-level entry point for investors researching Pepgen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pepgen Inc. (Ticker: PEPG) is a publicly traded company based in the United States, with a market capitalization of approximately $133.5 million. The company is focused on developing innovative therapies for genetic diseases. Pepgen aims to address unmet medical needs through its advanced research and development efforts.

- Ticker
- PEPG:BOATS
- Asset type
- Stock
- Market cap
- $206.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Pepgen Inc. PEPG:BOATS stock context
This page tracks Pepgen Inc.'s PEPG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PEPG:BOATS. PEPG:BOATS is the stock-level entry point for investors researching Pepgen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pepgen Inc. (Ticker: PEPG) is a publicly traded company based in the United States, with a market capitalization of approximately $133.5 million. The company is focused on developing innovative therapies for genetic diseases. Pepgen aims to address unmet medical needs through its advanced research and development efforts.
Latest news from Pepgen Inc.
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 6, 2026
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
August 6, 2026
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Pro...
May 21, 2026
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 12, 2026
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safe...
March 30, 2026
Pepgen Inc. earnings calls
Research Pepgen Inc.
Pepgen Inc. investor report
Review AI stock analysis and investor report context for PEPG:BOATS.
Pepgen Inc. company profile
View the public company page for Pepgen Inc. on 6ix.
Pepgen Inc. news
Read company news and market updates connected to Pepgen Inc..
Pepgen Inc. investor events
Find investor webinars, events, and replay context for Pepgen Inc..